4D Biomaterials | $4,373,097 | (Jul 26, 2024)
Micropep Technologies | $29,000,000 | (Jul 26, 2024)
TRiCares GmbH | $50,000,000 | (Jul 26, 2024)
Certified by Founder
Lodge
Brixton Biosciences
start up
United States
- Cambridge, MA
- 15/05/2024
- Series B
- $33,000,000
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
- Industry Biotechnology Research
- Website https://www.brixtonbio.com/
- LinkedIn https://www.linkedin.com/company/brixtonbiosciences/
SirenOpt | $6,600,000 | (Jul 26, 2024)
Jarvis | $2,315,016 | (Jul 26, 2024)
Archera | $17,000,000 | (Jul 26, 2024)
Noded Ai | $4,000,000 | (Jul 26, 2024)
NAVIGANTIS | $12,000,000 | (Jul 26, 2024)
GEOH | $3,000,000 | (Jul 26, 2024)
Addionics | $39,000,000 | (Jul 26, 2024)
Fractile | $15,000,000 | (Jul 26, 2024)
HASH | $10,000,000 | (Jul 26, 2024)